Year Founded
2004
Ownership
Private
Employees
~5000
Therapeutic Areas
OtherOncologyRare Diseases
Stage
Other
Modalities
Gene therapyRadiopharmaceuticalsSmall moleculeProtein therapeutics

Aixial General Information

CRO conducting over 1580 studies across Phase I-IV, with trial sizes up to 33,189 patients across 610 sites globally

Contact Information

Website
Primary Industry
[ "CRO" ]
Corporate Office
,

Drug Pipeline

No pipeline data available

For full access to Aixial's pipeline data

Book a demo

Key Partnerships

ALTEN Group, Medidata

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Aixial Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Aixial's complete valuation and funding history, request access »